Summary
HHS/ASPR (BARDA) issued Solicitation 75A50126R00002 seeking late-stage clinical development, regulatory approval, and procurement of 2-PAM autoinjectors as a drug/device combination to treat organophosphate poisoning (including nerve agents) for adult and pediatric populations and for placement in the SNS/CHEMPACK program. The work covers program management, device development and human factors, manufacturing validation lots, regulatory support for EUA and/or FDA approval, and procurement of up to 2 million autoinjectors with an initial 36-month base period. The solicitation was posted on SAM.gov on 2026-06-16 and has a response deadline of 2026-07-30 at 17:00 EDT (2026-07-30T21:00:00Z).